Literature DB >> 9505172

Epidemiological study of Cryptosporidium parvum antibodies [corrected] in sera of persons from Germany.

F Petry1.   

Abstract

In a seroprevalence study including 495 sera from persons of all age-groups, the presence of anti-Cryptosporidium parvum antibodies was evaluated in an enzyme immunoassay. Despite the fact that C. parvum is only found in approximately 2% of patients with diarrhea in Germany, specific antibodies could be detected in 15.4% of all samples. This figure indicates that a substantial proportion of the German population has been confronted with this parasite and it raises the question of whether C. parvum is a potential health risk to the general population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505172     DOI: 10.1007/BF02768744

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Increased exposure to cryptosporidia among dairy farmers in Wisconsin.

Authors:  E J Lengerich; D G Addiss; J J Marx; B L Ungar; D D Juranek
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

Review 2.  Cryptosporidiosis: an emerging, highly infectious threat.

Authors:  R L Guerrant
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

3.  Cryptosporidium sp. in stool specimens from diarrhoeic and asymptomatic individuals in the Magdeburg area (East Germany).

Authors:  W Schuster; R Fischer; S Alsleben; B Schuster
Journal:  Angew Parasitol       Date:  1991-11

4.  [Detection methods and occurrence of Cryptosporidium sp. in selected surface waters].

Authors:  V Gornik; M Exner
Journal:  Zentralbl Hyg Umweltmed       Date:  1991-09

5.  Seroepidemiologic study of Cryptosporidium infection in children from rural communities of Anhui, China and Fortaleza, Brazil.

Authors:  S X Zu; J F Li; L J Barrett; R Fayer; S Y Shu; J F McAuliffe; J K Roche; R L Guerrant
Journal:  Am J Trop Med Hyg       Date:  1994-07       Impact factor: 2.345

6.  Low prevalence of intestinal cryptosporidiosis among immunocompetent and immunocompromised patients with and without diarrhoea in southern Germany.

Authors:  W Kern; S Mayer; P Kreuzer; E Vanek
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

7.  Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts.

Authors:  F Petry; H A Robinson; V McDonald
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

8.  Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons.

Authors:  B L Ungar; R Soave; R Fayer; T E Nash
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

9.  Cryptosporidiosis in hospital personnel. Evidence for person-to-person transmission.

Authors:  K L Koch; D J Phillips; R C Aber; W L Current
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

10.  Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence.

Authors:  T L Kuhls; D A Mosier; D L Crawford; J Griffis
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

View more
  3 in total

1.  Serological responses to Cryptosporidium infection.

Authors:  T B Muller; F J Frost; G F Craun; R L Calderon
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Microbiological safety of drinking water: United States and global perspectives.

Authors:  T E Ford
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

Review 3.  Speculation on whether a vaccine against cryptosporidiosis is a reality or fantasy.

Authors:  D C de Graaf; F Spano; F Petry; S Sagodira; A Bonnin
Journal:  Int J Parasitol       Date:  1999-08       Impact factor: 3.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.